BACKGROUND: Sleep disturbance is associated with dopamine dysregulation, which can negatively impact immune status. Individuals living with HIV experience more sleep difficulties, and poor sleep may compound immune decrements associated with HIV infection. Little research has examined associations between sleep, dopamine, and immune status (CD4 count) in individuals with HIV. As ethnic minority women living with HIV (WLWH) are at heightened risk for HIV disease progression, we related sleep reports to both CD4 count and dopamine levels in a cohort of ethnic minority WLWH. METHODS: Participants were 139 low-income WLWH (ages 20-62; 78.3% African-American or Caribbean) who reported both overall sleep quality and sleep disturbance on the Pittsburgh sleep quality index (PSQI). CD4 count and HIV viral load were measured via morning peripheral venous blood samples, and concentrations of dopamine were measured via 24-h urine collection. Covariates included HIV viral load, length of time since HIV diagnosis, HAART adherence, perceived stress and depression. RESULTS: After controlling for all covariates, greater sleep disturbance was associated with significantly lower CD4 count (β=-.20, p=.03) and lower levels of dopamine (β=-.25, p=.04). Poorer overall sleep quality was marginally associated with lower CD4 count (β=-.16, p=.08), and was not associated with dopamine. CONCLUSION: Our analyses suggest that sleep disturbance is independently related with immune status and dopamine levels in WLWH. Lower levels of dopamine may indicate neuroendocrine dysregulation and may impact immune and health status. Results highlight sleep disturbance rather than overall sleep quality as potentially salient to neuroendocrine and immune status in ethnic minority WLWH.
BACKGROUND:Sleep disturbance is associated with dopamine dysregulation, which can negatively impact immune status. Individuals living with HIV experience more sleep difficulties, and poor sleep may compound immune decrements associated with HIV infection. Little research has examined associations between sleep, dopamine, and immune status (CD4 count) in individuals with HIV. As ethnic minority women living with HIV (WLWH) are at heightened risk for HIV disease progression, we related sleep reports to both CD4 count and dopamine levels in a cohort of ethnic minority WLWH. METHODS:Participants were 139 low-income WLWH (ages 20-62; 78.3% African-American or Caribbean) who reported both overall sleep quality and sleep disturbance on the Pittsburgh sleep quality index (PSQI). CD4 count and HIV viral load were measured via morning peripheral venous blood samples, and concentrations of dopamine were measured via 24-h urine collection. Covariates included HIV viral load, length of time since HIV diagnosis, HAART adherence, perceived stress and depression. RESULTS: After controlling for all covariates, greater sleep disturbance was associated with significantly lower CD4 count (β=-.20, p=.03) and lower levels of dopamine (β=-.25, p=.04). Poorer overall sleep quality was marginally associated with lower CD4 count (β=-.16, p=.08), and was not associated with dopamine. CONCLUSION: Our analyses suggest that sleep disturbance is independently related with immune status and dopamine levels in WLWH. Lower levels of dopamine may indicate neuroendocrine dysregulation and may impact immune and health status. Results highlight sleep disturbance rather than overall sleep quality as potentially salient to neuroendocrine and immune status in ethnic minority WLWH.
Authors: Stefan Cohrs; Zhenghua Guan; Kathrin Pohlmann; Wolfgang Jordan; Jürgen Pilz; Eckart Rüther; Andrea Rodenbeck Journal: Neurosci Lett Date: 2004-04-29 Impact factor: 3.046
Authors: V P Chekhonin; V P Baklaushev; B M Kogan; E A Savchenko; S V Lebedev; I V Man'kovskaya; T S Filatova; I U Yusupova; T B Dmitrieva Journal: Bull Exp Biol Med Date: 2000-08 Impact factor: 0.804
Authors: Rowan Saloner; Maria J Marquine; Erin E Sundermann; Suzi Hong; John Allen McCutchan; Ronald J Ellis; Robert K Heaton; Igor Grant; Mariana Cherner Journal: J Acquir Immune Defic Syndr Date: 2019-08-15 Impact factor: 3.731
Authors: Md Dilshad Manzar; Peter Sony; Mohammed Salahuddin; Abera Kumalo; Mathewos Geneto; Seithikurippu R Pandi-Perumal; Adam Moscovitch; Ahmed S BaHammam Journal: Sleep Sci Date: 2017 Apr-Jun
Authors: Shia T Kent; Greer A Burkholder; Gabriel S Tajeu; E Turner Overton; Paul Muntner Journal: Curr Hypertens Rep Date: 2015-11 Impact factor: 5.369
Authors: Julie A Womack; Terrence E Murphy; Harini Bathulapalli; Kathleen M Akgün; Cynthia Gibert; Kenneth M Kunisaki; Maria Rodriguez-Barradas; H Klar Yaggi; Amy C Justice; Nancy S Redeker Journal: J Assoc Nurses AIDS Care Date: 2017-02-16 Impact factor: 1.354
Authors: Chayakrit Krittanawong; Neil Maitra; Anirudh Kumar; Joshua Hahn; Zhen Wang; Daniela Carrasco; Hong Ju Zhang; Tao Sun; Hani Jneid; Salim S Virani Journal: Am J Cardiovasc Dis Date: 2022-08-15
Authors: Cecilia M Shikuma; Lindsay Kohorn; Robert Paul; Dominic C Chow; Kalpana J Kallianpur; Maegen Walker; Scott Souza; Louie Mar A Gangcuangco; Beau K Nakamoto; Francis D Pien; Timothy Duerler; Linda Castro; Lorna Nagamine; Bruce Soll Journal: HIV Clin Trials Date: 2018-11-19
Authors: Zanjbeel Mahmood; Andrea Hammond; Rodolfo A Nunez; Michael R Irwin; April D Thames Journal: J Int Neuropsychol Soc Date: 2018-08-31 Impact factor: 2.892